Disease Screening in Public Health

Cancer is a classical field for screening because of both the improvement of the prognosis for most cancers and the usually long incubation period. This part of the MOOC will present current data, evidence and policies regarding the most important cancer sites that include colorectum, prostate, lung, cervix, breast and skin. This module is given by several experts including Elisabetta Rapiti from the Geneva Cancer Registry at the Institute of Global Health in Geneva; Professor Antoine Flahault, who is the Head of the Institute of Global Health in Geneva; and Jean-Luc Buillard who is a Senior Lecturer in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. A quiz will complete this module.

This module explores the topics of public mental health and screening in the ageing population for neuropsychiatric conditions and physical impairments such as hearing loss. This module is given by several experts including Emiliano Albanese, assistant professor in public mental health in the Department of Psychiatry at the University of Geneva and the Director of the WHO Collaborating Center for Research and Training in mental health at the University of Geneva; Professor Christophe Bula who is the head of the geriatric and geriatric rehabilitation service at the Vaudois University Hospital Centre; Professor Armin von Gunten who is the head of the university service for geriatric psychiatry at the Vaudois University Hospital Service. A quiz will complete this module.

The globalization of non-communicable diseases is a major challenge in low and middle income countries (LMIC). At the same time, migration is occurring between these countries and high income countries. Screening for cardiovascular diseases and for cancer in low and middle income countries will be presented and discussed. In addition, the special consideration of screening of migrants from these countries will be addressed. This module is given by: Professor Pascal Bovet from the Division of Chronic Diseases at the Institute of Social and Preventive Medicine in Lausanne; Dr. Catherine Sauvaget from the International Agency for Research on Cancer (IARC) in Lyon, France; and Professor Patrick Bodenmann from the Polimedical University Clinic and head of the Centre for Vulnerable Populations. A quiz will complete this module.

In this final module, important aspects of for the evaluation, planning and decision making about the implementation or stopping of screening programs will be presented. This material is given by Senior lecturer Jean-Luc Bulliard who is an epidemiologist in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. The conclusion of the module will be a series of interviews with experts on the future of disease screening in public health conducted by Dr. Gillian Bartlett-Esquilant, a visiting professor at the Institute for Social and Preventive Medicine at Lausanne. A quiz will close this module.